Additionally, recent evolutionary pathways have been identified in instances of PT with a previous history of fibroadenoma showing mutations in MED12, TERT, TP53, RARA, and PIK3CA in tumor progression [9]. This evidence concerns the gene MED12 and Fibroadenoma.